Goujard C - Search Results

1

Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.

Seng R, Goujard C, Krastinova E, Miailhes P, Orr S, Molina JM, Saada M, Piroth L, Rouzioux C, Meyer L; ANRS PRIMO Cohort. Seng R, et al. Among authors: goujard c. AIDS. 2015 Mar 13;29(5):595-607. doi: 10.1097/QAD.0000000000000571. AIDS. 2015. PMID: 25715104

2

Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection.

Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, Ly TD, Goujard C, Guillet JG, Gomard E. Lamhamedi-Cherradi S, et al. Among authors: goujard c. AIDS. 1995 May;9(5):421-6. AIDS. 1995. PMID: 7639966

3

Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group.

De Vincenzi I, Jadand C, Couturier E, Brunet JB, Gallais H, Gastaut JA, Goujard C, Deveau C, Meyer L. De Vincenzi I, et al. Among authors: goujard c. AIDS. 1997 Mar;11(3):333-8. doi: 10.1097/00002030-199703110-00011. AIDS. 1997. PMID: 9147425

4

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study Group.

Carré N, Boufassa F, Hubert JB, Chavance M, Rouzioux C, Goujard C, Laurian Y, Meyer L. Carré N, et al. Among authors: goujard c. Int J Epidemiol. 1998 Oct;27(5):897-903. doi: 10.1093/ije/27.5.897. Int J Epidemiol. 1998. PMID: 9839750

5

Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.

Martinon F, Michelet C, Peguillet I, Taoufik Y, Lefebvre P, Goujard C, Guillet JG, Delfraissy JF, Lantz O. Martinon F, et al. Among authors: goujard c. AIDS. 1999 Feb 4;13(2):185-94. doi: 10.1097/00002030-199902040-00006. AIDS. 1999. PMID: 10202824

6

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.

Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C, Gastaut JA, Oksenhendler E, Boumsell L, Gomard E, Rabian C, Weiss L, Guillet JG, Delfraissy JF, Aboulker JP, Seligmann M. Levy Y, et al. Among authors: goujard c. Lancet. 1999 Jun 5;353(9168):1923-9. doi: 10.1016/s0140-6736(98)07345-0. Lancet. 1999. PMID: 10371571 Clinical Trial.

7

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Dalod M, Dupuis M, Deschemin JC, Goujard C, Deveau C, Meyer L, Ngo N, Rouzioux C, Guillet JG, Delfraissy JF, Sinet M, Venet A. Dalod M, et al. Among authors: goujard c. J Clin Invest. 1999 Nov;104(10):1431-9. doi: 10.1172/JCI7162. J Clin Invest. 1999. PMID: 10562305 Free PMC article.

8

[Primary HIV-1 infection].

Meyer L, Goujard C. Meyer L, et al. Among authors: goujard c. Rev Prat. 1999 Oct 15;49(16):1750-5. Rev Prat. 1999. PMID: 10578605 French.

9

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.

Guérin S, Meyer L, Theodorou I, Boufassa F, Magierowska M, Goujard C, Rouzioux C, Debré P, Delfraissy JF; SEROCO/HEMOCO Study Group. Guérin S, et al. Among authors: goujard c. AIDS. 2000 Dec 1;14(17):2788-90. doi: 10.1097/00002030-200012010-00020. AIDS. 2000. PMID: 11125899 No abstract available.

10

Incidence of clinical lipodystrophy in HIV-infected patients treated during primary infection.

Goujard C, Boufassa F, Deveau C, Laskri D, Meyer L; PRIMO group. Goujard C, et al. AIDS. 2001 Jan 26;15(2):282-4. doi: 10.1097/00002030-200101260-00024. AIDS. 2001. PMID: 11216943 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page